Publications

Publications

Filter Results: (2) Arrow Down

Show Results For

Page 1 of 2 Results
  • May 2016
  • Case

AbbVie

By: Kevin Schulman, Laura Little, Samyukta Mullangi and Stephen Schleicher
This case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars... View Details
Keywords: Pharmaceutical Company; M＆A Valuation; AbbVie; Health Care; Health Care and Treatment; Pharmaceutical Industry; Health Industry; United States
Related
  • 06 Jun 2017
  • First Look

First Look at New Research and Ideas: June 6, 2017

these challenges, co-founder Sr. Alphonsa finds hope in her favorite African proverb, “Your heart can take you where your feet cannot.” Purchase this case:https://cb.hbsp.harvard.edu/cbmp/product/317085-PDF-ENG Harvard Business School Case 316-095 View Details
Keywords: Sean Silverthorne